GOLDMAN SACHS GROUP INC - THESEUS PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

THESEUS PHARMACEUTICALS INC's ticker is and the CUSIP is 88369M101. A total of 70 filers reported holding THESEUS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.6%.

Links
Filings
Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of THESEUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$0
-100.0%
30,366
+78.8%
0.00%–
Q4 2023$68,777
-74.5%
16,982
-41.3%
0.00%–
Q2 2023$270,020–28,941–0.00%–
 Download
Other shareholders

There were no reported owners of THESEUS PHARMACEUTICALS INC in Q2 2023.

NameSharesValueWeighting ↓
View complete list of THESEUS PHARMACEUTICALS INC shareholders